Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol inhalation for mucus clearance in palliative care patients
2020-004377-44Phase 4Completed
- Sponsor
- Medical University of Vienna, Division of Palliative Medicine
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cancer and airway morbidity comparing Ambroxol inhalation with Placebo inhalation (2 arms). Primary endpoint: Patients' Global Impression of Change (PGIC). Started Jul 2021; status: completed.
02
Drugs
ambroxol
03
Conditions
cancerairway morbidity
Beyond the preview
Go deeper on 2020-004377-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004377-44.